Difference between revisions of "PMID:1656457"

From omp dev
Jump to: navigation, search
(Table edited by KSharma via TableEdit)
(References)
 
(10 intermediate revisions by 2 users not shown)
Line 53: Line 53:
 
|-  
 
|-  
 
|
 
|
gyrB truncation (where?), Arg136 (to what?)
+
a mutation or genetic difference within a strain
 
|
 
|
*Taxon: E.coli- Strain: K12
+
*Taxon: Escherichia coli
 +
*Strain: K-12
 +
*Substrain: RYC1000
 +
*NCBI Taxon ID: [http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=83333&lvl=3&lin=f&keep=1&srchmode=1&unlock 83333]
 
|
 
|
*Genotype of Reference Strain: Genes used: pop3351 (recA+, gyrB+), RYC10121 (recA56 gyrB+), RYC1010 (recA56 gyrB+) Mutants of RYC1010: RYC1020 (gyrB320) = R136L, RYC1021 (gyrB321 = R136C), RYC1022 (gyrB322). RYC1010 able to grow on M63 plates.
+
*Genotype of Reference Strain: ''gyrB<sup>+</sup>''
 +
*Genotype of Experimental Strain : Multi-copy ''gyrB'' in RYC1010
 
|
 
|
*Reference Condition: Liquid and solid rich LB media and minimal M63 media. These plates had 30ug/ml ampicillin, 20ug/ml tetracycline and 30ug/ml kanamycin. M63 plate contained coumermycin A1 at 16 ug/ml.
+
*Reference Condition: without coumermycin
 +
*Experimental Condition: With Coumermycin
 
|
 
|
  
Line 69: Line 74:
  
 
|
 
|
 
+
The plasmid pCID549 was used to increase gene dosage of ''gyrB'' causing increased resistance toward coumermycin A<sub>1</sub>.
 
|
 
|
 
   
 
   
Line 76: Line 81:
 
a mutation or genetic difference within a strain
 
a mutation or genetic difference within a strain
 
|
 
|
*Taxon: Escherichia coli
+
*Taxon: E-coli
*Strain: K-12
+
*Strain: K12
*Substrain: Pop3351
+
*Substrain: RYC1010
 
*NCBI Taxon ID: [http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=83333&lvl=3&lin=f&keep=1&srchmode=1&unlock 83333]
 
*NCBI Taxon ID: [http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=83333&lvl=3&lin=f&keep=1&srchmode=1&unlock 83333]
 
|
 
|
 
*Genotype of Reference Strain: ''gyrB<sup>+</sup>''
 
*Genotype of Reference Strain: ''gyrB<sup>+</sup>''
 +
*Genotype of Experimental Strain : ''gyrB(del)''
 
|
 
|
 
*Reference Condition:
 
*Reference Condition:
Line 93: Line 99:
  
 
|
 
|
 +
- Unusual mechanism of Ecoli gene gyrB resistance to the antibody  coumermycin.
 +
 +
- Single mutations at Arg-136 resulted in high level resistance to coumermycin A1, which concludes that this position in the gyrB gene is essential for coumermycin binding.
 +
 +
- Refer to fig 3 in the article to see the gyrB polypeptide and the positions where mutation took place.
  
 
|
 
|
Line 106: Line 117:
 
|
 
|
 
*Genotype of Reference Strain: ''gyrB<sup>+</sup>''
 
*Genotype of Reference Strain: ''gyrB<sup>+</sup>''
*Genotype of Experimental Strain : "gyrB(del)"
+
*Genotype of Experimental Strain : ''gyrB(truncated)''
 
|
 
|
*Reference Condition:
+
*Reference Condition: without coumermycin
 +
*Experimental Condition: with coumermycin
 
|
 
|
  
Line 118: Line 130:
  
 
|
 
|
- Unusual mechanism of Ecoli gene gyrB resistance to the antibody  coumermycin.
+
Plasmid pCID511.25 was constructed by eliminating 3' end of ''gyrB'' (removal of ''PvuII'' fragment, or elimination of the last 168 nucleotides). The gene only conferred resistance to coumermycin at 30C but not at 42C.  
 
 
- Single mutations at Arg-136 resulted in high level resistance to coumermycin A1, which concludes that this position in the gyrB gene is essential for coumermycin binding.
 
 
 
- Refer to fig 3 in the article to see the gyrB polypeptide and the positions where mutation took place.  
 
 
 
 
|
 
|
 
   
 
   
Line 140: Line 147:
  
 
[[Category:Publication]]
 
[[Category:Publication]]
 +
[[Category:Papers referenced in the LaRossa chapter]]

Latest revision as of 17:02, 25 October 2012

Citation

del Castillo, I, Vizán, JL, Rodríguez-Sáinz, MC and Moreno, F (1991) An unusual mechanism for resistance to the antibiotic coumermycin A1.Proc. Natl. Acad. Sci. U.S.A. 88:8860-4

Abstract

Bacterial DNA gyrases are type II topoisomerases made up of two A subunits and two B subunits. Coumarins are carbohydrate-containing antibiotics that inhibit topoisomerases II by competing with ATP for binding to the enzymes. High resistance to coumarins is produced in bacterial species by mutations in gyrB, the gene encoding subunit B. We have found an unusual mechanism of resistance to coumarins in Escherichia coli. This mechanism is exhibited by cells containing the wild-type gyrB, or its 5' half, in high copy number. Since homologous mutant gyrB (coumermycin resistant) truncated genes did not confer drug resistance at all under the same conditions, we propose that this mechanism of resistance is due to drug sequestration by the overproduced wild-type GyrB polypeptides. A corollary of this is that the amino half of GyrB is required and sufficient to fashion the ATP-binding domain of DNA gyrase, a conclusion that was further supported by mapping three independent coumarin-resistant mutations at Arg-136 of GyrB. Just upstream of this residue there is a glycine-rich sequence highly conserved in all topoisomerases II, which seems to be a good candidate for the actual ATP-binding site.

Links

PubMed

Keywords

Amino Acid Sequence; Aminocoumarins; Cloning, Molecular; Codon; Coumarins; DNA Mutational Analysis; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Gene Expression; Genes, Bacterial; Molecular Sequence Data; Plasmids; Restriction Mapping

Main Points of the Paper

Please summarize the main points of the paper.

Materials and Methods Used

Please list the materials and methods used in this paper (strains, plasmids, antibodies, etc).

Phenotype Annotations

See Help:AnnotationTable for details on how to edit this table.
<protect>

Phenotype of Taxon Information Genotype Information (if known) Condition Information OMP ID OMP Term Name ECO ID ECO Term Name Notes Status

a mutation or genetic difference within a strain

  • Taxon: Escherichia coli
  • Strain: K-12
  • Substrain: RYC1000
  • NCBI Taxon ID: 83333
  • Genotype of Reference Strain: gyrB+
  • Genotype of Experimental Strain : Multi-copy gyrB in RYC1010
  • Reference Condition: without coumermycin
  • Experimental Condition: With Coumermycin

The plasmid pCID549 was used to increase gene dosage of gyrB causing increased resistance toward coumermycin A1.

a mutation or genetic difference within a strain

  • Taxon: E-coli
  • Strain: K12
  • Substrain: RYC1010
  • NCBI Taxon ID: 83333
  • Genotype of Reference Strain: gyrB+
  • Genotype of Experimental Strain : gyrB(del)
  • Reference Condition:

- Unusual mechanism of Ecoli gene gyrB resistance to the antibody coumermycin.

- Single mutations at Arg-136 resulted in high level resistance to coumermycin A1, which concludes that this position in the gyrB gene is essential for coumermycin binding.

- Refer to fig 3 in the article to see the gyrB polypeptide and the positions where mutation took place.

a mutation or genetic difference within a strain

  • Taxon: E-coli
  • Strain: K12
  • Substrain: RYC1010
  • NCBI Taxon ID: 83333
  • Genotype of Reference Strain: gyrB+
  • Genotype of Experimental Strain : gyrB(truncated)
  • Reference Condition: without coumermycin
  • Experimental Condition: with coumermycin

Plasmid pCID511.25 was constructed by eliminating 3' end of gyrB (removal of PvuII fragment, or elimination of the last 168 nucleotides). The gene only conferred resistance to coumermycin at 30C but not at 42C.


</protect>

Notes

References

See Help:References for how to manage references in omp dev.